相似文献
1
Why asthma might surprisingly protect against poor outcomes in COVID-19.
Eur Respir J. 2020 Dec 10;56(6). doi: 10.1183/13993003.03045-2020. Print 2020 Dec.
2
Covid-19: reduced asthma presentations in children.
BMJ. 2020 Jul 15;370:m2806. doi: 10.1136/bmj.m2806.
3
Asthma and COPD in Hospitalized COVID-19 Patients.
Arch Bronconeumol (Engl Ed). 2020 Sep;56(9):604-606. doi: 10.1016/j.arbres.2020.05.007. Epub 2020 May 31.
4
SARS-CoV-2 Pneumonia in Hospitalized Asthmatic Patients Did Not Induce Severe Exacerbation.
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2600-2607. doi: 10.1016/j.jaip.2020.06.032. Epub 2020 Jun 27.
5
Asthma and COVID-19: Is asthma a risk factor for severe outcomes?
Allergy. 2020 Jul;75(7):1543-1545. doi: 10.1111/all.14348.
6
Does asthma affect morbidity or severity of COVID-19?
J Allergy Clin Immunol. 2020 Jul;146(1):55-57. doi: 10.1016/j.jaci.2020.05.017. Epub 2020 May 26.
7
Pediatric Hospitalizations During the COVID-19 Pandemic.
Pediatrics. 2020 Dec;146(6). doi: 10.1542/peds.2020-005983. Epub 2020 Nov 3.
8
Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization.
Respir Med. 2020 Sep;171:106084. doi: 10.1016/j.rmed.2020.106084. Epub 2020 Jul 4.
9
Prevalence, Characteristics, and Outcome of Asthmatic Patients With Type 2 Diseases in Hospitalized Patients With COVID-19 in Madrid, Spain.
J Investig Allergol Clin Immunol. 2020;30(5):382-384. doi: 10.18176/jiaci.0627. Epub 2020 Jun 18.
10
The Indirect Impact of COVID-19 on Children With Asthma.
Arch Bronconeumol (Engl Ed). 2020 Nov;56(11):768-769. doi: 10.1016/j.arbres.2020.07.003. Epub 2020 Aug 17.
引用本文的文献
1
TSLP pretreatment inhibits M1 macrophage polarization and attenuates LPS-induced iNKT cell-dependent acute lung injury.
Front Immunol. 2025 May 23;16:1583235. doi: 10.3389/fimmu.2025.1583235. eCollection 2025.
2
Characterizing the Association Between Asthma and Clinical Outcomes in Emergency Department Patients With Symptomatic COVID-19.
Cureus. 2025 Feb 25;17(2):e79657. doi: 10.7759/cureus.79657. eCollection 2025 Feb.
3
Association between asthma and COVID-19 severity during Omicron epidemic: a retrospective cohort study using real-world data.
BMC Infect Dis. 2024 Jul 4;24(1):667. doi: 10.1186/s12879-024-09520-9.
4
Spatial Survival Model for COVID-19 in México.
Healthcare (Basel). 2024 Jan 24;12(3):306. doi: 10.3390/healthcare12030306.
5
Bacterial Proteases as Potentially Exploitable Modulators of SARS-CoV-2 Infection: Logic from the Literature, Informatics, and Inspiration from the Dog.
BioTech (Basel). 2023 Oct 30;12(4):61. doi: 10.3390/biotech12040061.
6
Epidemiology and Immunopathogenesis of Virus Associated Asthma Exacerbations.
J Asthma Allergy. 2023 Sep 26;16:1025-1040. doi: 10.2147/JAA.S277455. eCollection 2023.
7
Endothelial Glycocalyx Injury in SARS-CoV-2 Infection: Molecular Mechanisms and Potential Targeted Therapy.
Mediators Inflamm. 2023 Aug 29;2023:6685251. doi: 10.1155/2023/6685251. eCollection 2023.
8
Predictors of pulmonary embolism in hospitalized patients with COVID-19.
Thromb J. 2023 Jul 3;21(1):73. doi: 10.1186/s12959-023-00518-y.
9
Characteristics and outcomes of asthmatic outpatients with COVID-19 who receive home telesurveillance.
ERJ Open Res. 2022 Oct 24;8(4). doi: 10.1183/23120541.00012-2022. eCollection 2022 Oct.
10
Clinical benefits of inhaled ciclesonide for hospitalized patients with COVID-19 infection: a retrospective study.
BMC Pulm Med. 2022 Sep 28;22(1):368. doi: 10.1186/s12890-022-02168-8.
本文引用的文献
1
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon.
J Allergy Clin Immunol. 2021 Feb;147(2):510-519.e5. doi: 10.1016/j.jaci.2020.09.034. Epub 2020 Oct 15.
2
Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation.
Eur Respir J. 2020 Nov 5;56(5). doi: 10.1183/13993003.01875-2020. Print 2020 Nov.
3
COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids.
Am J Respir Crit Care Med. 2020 Jul 1;202(1):83-90. doi: 10.1164/rccm.202003-0821OC.
4
Patterns of systemic and local inflammation in patients with asthma hospitalised with influenza.
Eur Respir J. 2019 Oct 24;54(4). doi: 10.1183/13993003.00949-2019. Print 2019 Oct.
5
Preexisting Type 2 Immune Activation Protects against the Development of Sepsis.
Am J Respir Cell Mol Biol. 2017 Nov;57(5):628-630. doi: 10.1165/rcmb.2017-0277LE.
6
Asthma Is Associated with a Lower Risk of Sepsis and Sepsis-related Mortality.
Am J Respir Crit Care Med. 2017 Sep 15;196(6):787-790. doi: 10.1164/rccm.201608-1583LE.
7
Overexpressing mouse model demonstrates the protective role of Muc5ac in the lungs.
Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16528-33. doi: 10.1073/pnas.1206552109. Epub 2012 Sep 24.
8
Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK.
Thorax. 2012 Aug;67(8):709-17. doi: 10.1136/thoraxjnl-2011-200266. Epub 2012 Mar 10.
9
Increased H1N1 infection rate in children with asthma.
Am J Respir Crit Care Med. 2012 Jun 15;185(12):1275-9. doi: 10.1164/rccm.201109-1635OC. Epub 2012 Feb 23.
10
Children with asthma hospitalized with seasonal or pandemic influenza, 2003-2009.
Pediatrics. 2011 Jul;128(1):e27-32. doi: 10.1542/peds.2010-3343. Epub 2011 Jun 6.
Zotero 插件